Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proleukin and DTIC in High-Risk Melanoma
NCT00553618Phase 2Active, not recruiting
- Sponsor
- University of Louisville
- Start
- Aug 2007
- Primary completion
- Aug 2025
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin, dacarbazine in melanoma, sponsored by University of Louisville. Started Aug 2007; status: active, not recruiting.
02
Drugs
aldesleukindacarbazine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00553618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553618.